Professional Documents
Culture Documents
Hidden Gems in Investor Presentations
Hidden Gems in Investor Presentations
The events, now online due to COVID 19, allow CEO’s of up and coming
companies the opportunity to present their case to interested investors.
Attendees have the opportunity to question the business leaders as well.
The full text of each presentation is available online at the FNN website for
interested investors to look for prospective investments. Although well-
known ASX stocks occasionally make presentations, the more typical
participants are companies in the earlier stages of development taking
advantage of the opportunity to make their investment case. They have
stories to tell, with some more compelling than others.
The following price movement chart from the ASX website tracks the year
over year share price movement of four interesting companies from the
November investor presentation events at FNN. These are the companies:
Galan has multiple lithium brine projects in the Argentina’s Hombre Muerto
Basin at Humberto Muerto West and Candelas. The company also has a
licence application for a project near the Greenbushes mine. In January of
2021Galan acquired an 80% interest in Lithium Australia’s (LIT)
Greenbushes South lithium project.
The share price slid as investors learned Galan planned a $50 million
dollar share placement to fund exploration and drilling progress along with
finalising feasibility studies at Humberto Muerto West and Candelas.
Galan has a market cap of $443 million dollars and last traded at $1.53 per
share.
In the past year, the company has achieved several product wins. The
Australian government signed a $4.1 million dollar deal to receive
Etherstack technology and associated delivery systems, with the potential
for additional business pending the successful completion of performance-
based targets.
Additional contracts signed during late 2020 through 2021 to date include
RCS Communications for a major Western Australian iron ore producer
(the second deal with this client); an AUD$500,000 subcontract with Electro
Optics Systems (EOS) to provide supply services to the Australian
Department of Defense; an AUD$11.6 million dollar deal with Samsung of
Korea for networking elements; and the Etherstack American subsidiary
company signed a USD$420,000 contract with US communications
conglomerate AT&T for software licences and equipment and needed
services to integrate the equipment.
Additional contracts were signed with the UK Ministry of Defence and the
Australian Department of Home Affairs.
On 23 November, the company issued new guidance for FY 2020, raising
both revenue and profit expectations. Etherstack has a market cap of $67
million dollars and last traded at $0.51 per share.
The company has two diagnostic products in place – the hTERT test to
supplement cytology testing for bladder cancers, and the EXO-NET® pan-
exosome capture tool for research purposes. Bard’s cancer diagnostic
pipeline includes tests in development for ovarian and breast cancers, and
research-stage projects for prostate and pancreatic cancers.
The share price exploded upwards following the release of successful test
results on a Bard compound for early diagnosis of ovarian cancer. The
share price got another boost back in March when a collaborative research
study with Minomic International found EXO-NET® successfully isolated
exosomes in a study of a Minomic pancreatic cancer treatment, before
returning to earth.
Carbonxt makes Activate Carbon (AC) powders and pellets for the
removal of pollutants generated from industrial processes. The company’s
principal market is the US and its clients include coal-fired electricity
generating plants, cement factories, and other applications with polluting
byproducts. The company has successfully reduced mercury and sulfur
emissions from coal-fired generating plants and has expanded its focus to
pollutant sources in wastewater treatment, potable water, and phosphate
removal.